Both in Pharmaceuticals
Corvus Pharmaceuticals vs MoonLake Immunotherapeutics
Over the past year CRVS returned +61.5% and MLTX returned +83.3%; their daily moves had a correlation of 0.11.
CRVS +61.5% MLTX +83.3%Growth of $1, one year, split-adjusted
| Metric | CRVS | MLTX |
|---|---|---|
| Price | $11.76 | $11.45 |
| Market cap | $989.3M | $974.5M |
| Today | −0.93% | −0.95% |
| 1 month | −16.9% | −23.6% |
| 6 months | −12.2% | −32.4% |
| Year to date | +52.7% | −13.1% |
| 1 year | +59.1% | −81.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $215.2M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 51.1% | 52.2% |
| Short % of float | 24.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).